Interleukin-22, a potent target for treatment of non-autoimmune diseases
نویسندگان
چکیده
منابع مشابه
P 86: CD166 as a Therapeutic Target in Autoimmune Diseases
About 3 decades ago CD6 identified as one of the first antigens expresses on the majority of T cells and a subset of B cells. CD6 regulates cellular adhesion migration across the endothelial and epithelial cells. In recent years researches indicate its role in pathogenesis of autoimmune diseases. Many researches have been done in recent years to block CD6 by CD6 mono clonal antibodies, IOR-T1 a...
متن کاملRole of Interleukin-37 in Inflammatory and Autoimmune Diseases
Interleukin-1 family 7 (IL-1F7) is a novel member of IL-1F cytokines. IL-1F7 is more commonly known as IL-37. IL-37 join the α-subunit of the IL-18 receptor, or IL-18 binding protein (IL-18BP), and binding of these proteins can enhance the IL-18 suppression. IL-37 also translocates to the cell nucleus and affects gene transcription. IL-37 inhibits the phosphorylation of p38 mitogen-activated pr...
متن کاملInterleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases
Toshio Tanaka1, 2), Masashi Narazaki3), Kazuya Masuda4) and Tadamitsu Kishimoto4,*) 1)Department of Clinical Application of Biologics, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan 2)Department of Immunopathology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan 3)Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka Univ...
متن کاملP 53: Stem Cell Therapy for Treatment of Autoimmune Diseases (with Emphasis on Multiple Sclerosis)
Autoimmune diseases have been described as an interesting and poorly understood group of disorders. There are many challenges in the respective scientific societies concerning the nature, causes and the therapeutic approaches of these diseases. In accordance with the evidences the nature and etiology of these disorders is multifactorial and complex but the clearest definition could be expressed...
متن کاملp 86: cd166 as a therapeutic target in autoimmune diseases
about 3 decades ago cd6 identified as one of the first antigens expresses on the majority of t cells and a subset of b cells. cd6 regulates cellular adhesion migration across the endothelial and epithelial cells. in recent years researches indicate its role in pathogenesis of autoimmune diseases. many researches have been done in recent years to block cd6 by cd6 mono clonal antibodies, ior-t1 a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Human Vaccines & Immunotherapeutics
سال: 2018
ISSN: 2164-5515,2164-554X
DOI: 10.1080/21645515.2018.1509649